Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation
Authors:
- Wei GuoWGWei Guo
- Hongyun LuHLHongyun Lu
- Zhanguo GaoZGZhanguo Gao
- 30 June 2014
- journal article
- research article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 53 (2) , 191-200
Abstract
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor whose activation is dependent on a ligand. PPARγ activation by exogenous ligands, such as thiazolidinediones (TZDs), is a strategy in the treatment of type 2 diabetes mellitus for the improvement of insulin sensitivity. In addition to a ligand, PPARγ function is also regulated by posttranslational modifications, such as phosphorylation, sumoylation, and ubiquitination. Herein, we report that the PPARγ protein is modified by acetylation, which induces the PPARγ function in the absence of an external ligand. We observed that histone deacetylase 3 (HDAC3) interacted with PPARγ to deacetylate the protein. In immunoprecipitation assays, the HDAC3 protein was associated with the PPARγ protein. Inhibition of HDAC3 using RNAi-mediated knockdown or HDAC3 inhibitor increased acetylation of the PPARγ protein. Furthermore, inhibition of HDAC3 enhanced the expression of PPARγ target genes such as adiponectin and aP2. The expression was associated with an increase in glucose uptake and insulin signaling in adipocytes. HDAC3 inhibition enhanced lipid accumulation during differentiation of adipocytes. PPARγ acetylation was also induced by pioglitazone and acetylation was required for PPARγ activation. In the absence of TZDs, the acetylation from HDAC3 inhibition was sufficient to induce the transcriptional activity of PPARγ. Treating diet-induced obesity mice with HDAC3 inhibitor or pioglitazone for 2 weeks significantly improved high-fat-diet-induced insulin resistance. Our results indicate that acetylation of PPARγ is a ligand-independent mechanism of PPARγ activation. HDAC3 inhibitor is a potential PPARγ activator for the improvement of insulin sensitivity.Keywords
This publication has 45 references indexed in Scilit:
- Inhibition of Histone Deacetylase 3 Protects Beta Cells from Cytokine-Induced ApoptosisChemistry & Biology, 2012
- Challenges in drug discovery for thiazolidinedione substituteActa Pharmaceutica Sinica B, 2011
- Epigenetic codes of PPARγ in metabolic diseaseFEBS Letters, 2011
- Expression of the peroxisome proliferator activated receptor γ gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetesBMC Biology, 2009
- Fat and Beyond: The Diverse Biology of PPARγAnnual Review of Biochemistry, 2008
- Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage ControlMolecular Cell, 2008
- Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2Molecular and Cellular Biology, 2007
- Cleavage and Cytoplasmic Relocalization of Histone Deacetylase 3 Are Important for Apoptosis ProgressionMolecular and Cellular Biology, 2007
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- A Regulatory Role for RIP140 in Nuclear Receptor ActivationMolecular Endocrinology, 1998